Home Newsfeeds Benchmark Initiates Coverage On NOV with Hold Rating

Benchmark Initiates Coverage On NOV with Hold Rating

Benchmark analyst Doug Becker initiates coverage on NOV (NYSE:NOV) with a Hold rating.

byBenzinga Newsdesk

August 25, 2022

1 minute read

Benchmark analyst Doug Becker initiates coverage on NOV (NYSE:NOV) with a Hold rating.

Oppenheimer Maintains Outperform on LendingTree, Lowers Price Target to $35

By Benzinga Newsdesk

November 8, 7:58 AM

Oppenheimer analyst Jed Kelly maintains LendingTree (NASDAQ:TREE) with a Outperform and lowers the price target from $55 to $35.

TREE

Seagen’s Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa’s Current Market

By Vandana Singh

August 16, 2:12 PM

Earlier today, Seagen Inc (NASDAQ: SGEN) announced that the Phase 3 HER2CLIMB-02 clinical trial of Tukysa (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla) met its primary endpoint of

PFE

News

Montauk Renewables, Inc. Announces Second Apex Renewable Natural Gas Facility In Amsterdam, Ohio

By Benzinga Newsdesk

August 31, 3:50 PM

PITTSBURGH, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (NASDAQ:MNTK) (the "Company") announces the planned construction of a second renewable natural gas ("RNG") processing facility at

MNTK